The Ivermectin Cancer Protocol Guide

Executive Summary

• This article covers the factors that play into developing a recommended Ivermectin cancer protocol.

Introduction

We get many questions on the appropriate Ivermectin dose. In this article, we will cover the Ivermectin cancer protocol.

The Complications Of Arriving at an Ivermectin Cancer Protocol

The problem is that there are questions on an effective Ivermectin cancer protocol.

Why Ivermectin is Currently and Will Most Likely Only Ever be Approved by the FDA as an Antiparasitic Drug

Ivermectin is only approved by the FDA as an anti-parasitical and has been for over 50 years. But it is the likelihood is essentially zero that any pharmaceutical company will ever go to the expense to perform a clinical trial on Ivermectin to expand its usage, as there are no profits to be made from such an endeavor -- and that is the only way drugs are approved, a pharmaceutical company must invest the money into performing two clinical trials. The reason for this is that Ivermectin has already lost its patent. 

Pharmaceutical companies are far more likely to fund studies to undermine Ivermectin, as Bill Gates' foundation did with Hydroxychloroquine.

The US Government Health Authorities Are Aligned With Promoting Only Patent Drugs

Studies have continued on Ivermectin, but neither the NIH nor other pharmaceutical companies will fund them.

At the direction of pharmaceutical companies, the FDA actively discourages using Ivermectin and lies to the public about the studies on its effectiveness.

Case Study #1: The FDA’s Statement and Laetrile

This is concisely explained in the quote from William W Vodra, Former Associate Chief Council for the FDA.

No one is going to pay $70,000 for a new cancer drug if they can buy Laetrile for 75 cents.

Laetrile was a drug that was shut down in the 1970s by the medical establishment (specifically Sloan Kettering) that showed promise against cancer. Laetrile is the topic of the documentary The Lie of America's War on Cancer. However, this quote from Vodra is from the 1970s.

Today, the average new chemotherapy drug is over $200,000, and immunotherapy drugs are over $300,000.

What is curious about this admission by Vodra is that it is not made by a pharmaceutical company -- which would be entirely expected. Instead, it is made by a top official at the FDA.

When you can't distinguish quotes from pharmaceutical companies and a drug regulator like the FDA, one has to question how independent that drug regulator is. 

It's apparent that neither the FDA nor NIH cares about the evidence supporting Ivermectin. And this is not just an issue limited to Fenbendazole. While patent drugs constantly have their off-label usage expanded without any studies submitted to the FDA.

Two Different Standards That Are Applied to Drugs

Ivermectin will never expand its off-label use, even though it is legal to do so. See this quote from the FLCCC Alliance on how the double standard is applied. 

Once the FDA approves a prescription medication, federal laws allow any U.S. physician to prescribe the duly approved drug for any reason. In fact, around 30 percent of all prescriptions in the United States are for off-label uses, written by providers exercising their medical judgment. FDA-approved drugs like ivermectin may be prescribed for an unapproved use (“off-label”) when the provider believes it to be medically appropriate for their patients.

This is why the medical establishment finds it so crucial for MDs to give negative reinforcement for using Ivermectin for anything but as an antiparasitic. Ivermectin usage as an antiparasitic is for a much shorter duration and lower dosage than using Ivermectin against cancer. However, by contrast, antidepressants or statins constantly have their usage expanded without any new clinical trials being submitted because they are preferred drugs. 

Not only the MDs that pressure the medical establishment; pharmacies are also pressured. Many pharmacists consider an Ivermectin prescription a "red flag" and a reason to ask more questions. 

The reality is that generic drugs are considered drugs the pharmaceutical industry wants to de-emphasize -- hopefully (that is the hope of the pharmaceutical companies) to be replaced by an on-patent drug at some point in the future. In the case of drugs Paxlovid and Molnupiravir, both were promoted by the medical establishment to replace the generic Ivermectin versus covid, even though both were useless against covid and far more expensive than either Ivermectin or Fenbendazole and were far less safe drugs. The promotion of Paxlovid and Molnupiravir and the impression of Ivermectin by the medical establishment (including the FDA) and the establishment media should tell you all you need to know about how they work. 

The C19Early Clinical Trial Comparison Website

The C19early.com website tracks clinical trials. It is the best source of information on the studies of the effectiveness based upon clinical trials of different treatments for covid. However, it is more than this - as it is a model for how clinical trials should be communicated to the public so the corrupt medical establishment does not control the information. This is the website the medical establishment does not want you to see because they want to provide false information to the public to suppress the drug they don't make enough profit from. They want to be able to hide the actual results of the clinical trials from the public but then also say they are "following the science."

Even though this website does not track cancer clinical trials, I will use it to demonstrate how the medical establishment suppresses cost-effective treatments. They do this in all areas of medicine, so cancer treatments are not unique.

What The C19Early Website Shows

The website C19Early overturns their arguments on the effectiveness of the medical establishment's recommended treatments. It shows the effectiveness and low cost of treatments they try to hide from the public. This naturally shows them as the pharmaceutical company propagandists they are.

How This Example from Covid Generalizes for Cancer Treatments

Observe the comparative effectiveness of their favored treatments versus those they actively suppress. This example is taken from COVID-19 -- however, the medical authorities work the same way in terms of suppressing low-cost, effective treatments for cancer while promoting the most expensive and least effective -- and, in many cases, utterly ineffective cancer treatments.

Cost Per Life Saved for Covid

Notice that the top treatments per life saved ranked by cost are all-natural items.

• The reason is simple. Most people are deficient in Melatonin, Vitamin D, Vitamin C, and Zinc. These items address these deficiencies and allow the immune system to function correctly. 
• Ivermectin is listed as the subsequent most cost-effective treatment. Then HCQ or hydroxychloroquine is next after that. However, remember that the establishment media told us the HCQ was not effective against covid -- the primary reason they provided was that Trump said it was probably effective and that he took it and felt better.

Because the first four items (non-drugs) are much less expensive than Ivermectin or HCQ, they are more effective per dollar than the top four items. Every one of these treatments was suppressed by the medical establishment in favor of drugs like Molnupiravir, Paxlovid, and Remdesivir (the last being part of the official CDC protocol for COVID) -- even though these drugs are highly ineffective and far less safe than the items that scored the highest. Look at the cost per life saved versus the first items on the list. 

This is clear evidence that the medical establishment pushes people towards the most expensive and often far less effective treatments that are profit-maximizing for drug companies. Notice that the drug that was part of the covid protocol was Remdesivir -- as you can see at the end of the list -- has a cost of nearly $1.5 million per life saved. Why is this the recommended drug by the NIH and CDC? It should be obvious. 

The more expensive the treatment, the more likely the drug companies and medical establishment will want people to take that treatment -- and for very obvious reasons - the medical establishment is optimizing around the most expensive treatments. 

I cover this topic with a specific case study in How Merck Falsified the Clinical Trails of Molnupiravir to Replace Ivermectin.

Is There a C19Early Type Website for Cancer Treatments?

Unfortunately, there is no website like C19Early for cancer treatments. If one existed, it would be highly damaging to the claims of the cancer establishment. It would also show roughly the same thing -- with the medical establishment and cancer centers optimizing around the most expensive cancer treatments and not offering any of the lowest cost, most effective treatments. 

Ivermectin and Cancer

In addition to covid, Ivermectin also works against cancer. I cover the specific mechanisms by which it works at the subscription site.

What About a Different and Specific Ivermectin Cancer Protocol From Other Uses?

One subscriber commented that they expected a specific dosage for cancer. We developed an overall dosage that includes cancer. The dosage above incorporates multiple studies on cancer. However, because Ivermectin is good for so many things — immunomodulation as one example (which is covered in the article How Ivermectin Improves the Immune Response by Acting as an Immunomodulator)(Subscription Required) — which is part of its impact on cancer.

Ivermectin as an Immunomodulator

But, of course, immunomodulation supports the overall immune system and immune response. This is also only one of the ways that Ivermectin works against cancer, as covered in the article By How Many Different Mechanisms Does Ivermectin Fight Cancer? Given all of this, it’s difficult to separate the benefit of Ivermectin only for cancer and to say there should be an Ivermectin dose specific to cancer prevention and treatment. If we find studies that provide new information related to Ivermectin and cancer, that will change this. In that case, we will modify our recommended dosage and then break it into multiple dosage recommendations.

• This is an important insight related to the topic of using Ivermectin.
• Ivermectin should not be considered a treatment that does just one thing.

How the Usage of Ivermectin Tends to Expand the More You Know About It

For example, I started off taking Ivermectin to fight the impact of the covid vaccine that I was essentially coerced into taking. However, as I expanded my research into Ivermectin, I realized that Ivermectin is a Jack-of-all-Trades treatment. So, while it fights the spike protein from the mRNA vaccines, it does many other things in the body. And this leads to the next point and common question.

sc name=”expanding-ivermectin-usage”][/sc]

• We have Ivermectin dosage calculators based on research studies and for all the different uses of Ivermectin.
• We are the only web source offering an Ivermectin dosage calculator in addition to different dosage estimates for different cancer types.
• All of our calculators are easy to use (see our dosage calculator listing). Each person enters their personalized information into the calculator and receives our recommended extensively researched dosage estimate automatically and immediately calculated.
• We also cover the broader problems with dosage calculation in medicine at the article The Problem With Dosage Calculation in Medicine, as this is an issue much larger than for one drug. 

About Our Ivermecting Testing Program and Recommended Ivermectin Source of Supply

• We performed pharmaceutical testing on Ivermectin to find a lower-cost version that also matched Merck's original Ivermectin in bioequivalence.
• You can read about the details of our Ivermectin testing in this article, Our Ivermectin Bioequivalence Testing.
• We got Summit Products to carry this version of Ivermectin, which passed our bioequivalence testing. 

Sharing This Article

Share this article with a friend or family member by copying this article link and pasting it into your email so they can read the same information.